418 related articles for article (PubMed ID: 32247713)
1. Emerging Concepts of the Pathophysiology and Adverse Outcomes of Restless Legs Syndrome.
Romero-Peralta S; Cano-Pumarega I; García-Borreguero D
Chest; 2020 Sep; 158(3):1218-1229. PubMed ID: 32247713
[TBL] [Abstract][Full Text] [Related]
2. Non-dopaminergic vs. dopaminergic treatment options in restless legs syndrome.
Wanner V; Garcia Malo C; Romero S; Cano-Pumarega I; García-Borreguero D
Adv Pharmacol; 2019; 84():187-205. PubMed ID: 31229171
[TBL] [Abstract][Full Text] [Related]
3. The long-term treatment of restless legs syndrome/Willis-Ekbom disease: evidence-based guidelines and clinical consensus best practice guidance: a report from the International Restless Legs Syndrome Study Group.
Garcia-Borreguero D; Kohnen R; Silber MH; Winkelman JW; Earley CJ; Högl B; Manconi M; Montplaisir J; Inoue Y; Allen RP
Sleep Med; 2013 Jul; 14(7):675-84. PubMed ID: 23859128
[TBL] [Abstract][Full Text] [Related]
4. New concepts in the management of restless legs syndrome.
Garcia-Borreguero D; Cano-Pumarega I
BMJ; 2017 Feb; 356():j104. PubMed ID: 28242627
[TBL] [Abstract][Full Text] [Related]
5. Management of treatment failure in restless legs syndrome (Willis-Ekbom disease).
Garcia-Borreguero D; Cano-Pumarega I; Marulanda R
Sleep Med Rev; 2018 Oct; 41():50-60. PubMed ID: 29602660
[TBL] [Abstract][Full Text] [Related]
6. Living with Restless Legs Syndrome/Willis-Ekbom Disease.
Tachibana N
Sleep Med Clin; 2015 Sep; 10(3):359-67, xv. PubMed ID: 26329446
[TBL] [Abstract][Full Text] [Related]
7. Guidelines for the first-line treatment of restless legs syndrome/Willis-Ekbom disease, prevention and treatment of dopaminergic augmentation: a combined task force of the IRLSSG, EURLSSG, and the RLS-foundation.
Garcia-Borreguero D; Silber MH; Winkelman JW; Högl B; Bainbridge J; Buchfuhrer M; Hadjigeorgiou G; Inoue Y; Manconi M; Oertel W; Ondo W; Winkelmann J; Allen RP
Sleep Med; 2016 May; 21():1-11. PubMed ID: 27448465
[TBL] [Abstract][Full Text] [Related]
8. Restless legs syndrome/Willis Ekbom disease: evaluation and treatment.
Allen RP
Int Rev Psychiatry; 2014 Apr; 26(2):248-62. PubMed ID: 24892899
[TBL] [Abstract][Full Text] [Related]
9. Restless Legs Syndrome/Willis-Ekbom Disease Morbidity: Burden, Quality of Life, Cardiovascular Aspects, and Sleep.
Stevens MS
Sleep Med Clin; 2015 Sep; 10(3):369-73, xv-xvi. PubMed ID: 26329447
[TBL] [Abstract][Full Text] [Related]
10. Willis-Ekbom Disease Foundation revised consensus statement on the management of restless legs syndrome.
Silber MH; Becker PM; Earley C; Garcia-Borreguero D; Ondo WG;
Mayo Clin Proc; 2013 Sep; 88(9):977-86. PubMed ID: 24001490
[TBL] [Abstract][Full Text] [Related]
11. Treatment Options in Intractable Restless Legs Syndrome/Willis-Ekbom Disease (RLS/WED).
Rinaldi F; Galbiati A; Marelli S; Ferini Strambi L; Zucconi M
Curr Treat Options Neurol; 2016 Feb; 18(2):7. PubMed ID: 26874840
[TBL] [Abstract][Full Text] [Related]
12. Consensus clinical practice guidelines for the diagnosis and treatment of restless legs syndrome/Willis-Ekbom disease during pregnancy and lactation.
Picchietti DL; Hensley JG; Bainbridge JL; Lee KA; Manconi M; McGregor JA; Silver RM; Trenkwalder C; Walters AS;
Sleep Med Rev; 2015 Aug; 22():64-77. PubMed ID: 25553600
[TBL] [Abstract][Full Text] [Related]
13. An update on restless legs syndrome (Willis-Ekbom disease): clinical features, pathogenesis and treatment.
Garcia-Borreguero D; Williams AM
Curr Opin Neurol; 2014 Aug; 27(4):493-501. PubMed ID: 24978636
[TBL] [Abstract][Full Text] [Related]
14. An update on the treatment of Restless Legs Syndrome/Willis-Ekbom Disease: prospects and challenges.
Zucconi M; Galbiati A; Rinaldi F; Casoni F; Ferini-Strambi L
Expert Rev Neurother; 2018 Sep; 18(9):705-713. PubMed ID: 30095315
[TBL] [Abstract][Full Text] [Related]
15. Augmentation of restless leg syndrome (Willis-Ekbom disease) during long-term dopaminergic treatment.
Garcia-Borreguero D; Benitez A; Kohnen R; Allen R
Postgrad Med; 2015; 127(7):716-25. PubMed ID: 26077324
[TBL] [Abstract][Full Text] [Related]
16. Defining the phenotype of restless legs syndrome/Willis-Ekbom disease (RLS/WED): a clinical and polysomnographic study.
Rinaldi F; Galbiati A; Marelli S; Cusmai M; Gasperi A; Oldani A; Zucconi M; Padovani A; Ferini Strambi L
J Neurol; 2016 Feb; 263(2):396-402. PubMed ID: 26725086
[TBL] [Abstract][Full Text] [Related]
17. Update on Restless Legs Syndrome: from Mechanisms to Treatment.
Gonzalez-Latapi P; Malkani R
Curr Neurol Neurosci Rep; 2019 Jun; 19(8):54. PubMed ID: 31250128
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and quality of life and sleep in children and adolescents with restless legs syndrome/Willis-Ekbom disease.
Sander HH; Eckeli AL; Costa Passos AD; Azevedo L; Fernandes do Prado LB; França Fernandes RM
Sleep Med; 2017 Feb; 30():204-209. PubMed ID: 28215250
[TBL] [Abstract][Full Text] [Related]
19. Restless Legs Syndrome/Willis-Ekbom Disease and Periodic Limb Movements in Sleep in the Elderly with and without Dementia.
Figorilli M; Puligheddu M; Ferri R
Sleep Med Clin; 2015 Sep; 10(3):331-42, xiv-xv. PubMed ID: 26329443
[TBL] [Abstract][Full Text] [Related]
20. Restless Leg Syndrome/Willis-Ekbom disease in women with iron deficiency anemia.
Kolukisa M; Soysal P; Gületkin TÖ; Karatoprak C; Bilgen HR; Gürsoy AE
Ideggyogy Sz; 2016 Sep; 69(9-10):356-360. PubMed ID: 29638100
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
